Skip to content

The Archive · A Source

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

Molecular Therapy 2021 www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(20